Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Nov 14;6(11):e012185.
doi: 10.1136/bmjopen-2016-012185.

Use of the Diabetes Medication Choice Decision Aid in patients with type 2 diabetes in Greece: a cluster randomised trial

Thomas Karagiannis  1   2 , Aris Liakos  1   2 , Megan E Branda  3 , Eleni Athanasiadou  1 , Maria Mainou  1   2 , Panagiota Boura  2 , Dimitrios G Goulis  4 , Annie LeBlanc  5 , Victor M Montori  6 , Apostolos Tsapas  1   2   7
Affiliations
Randomized Controlled Trial

Use of the Diabetes Medication Choice Decision Aid in patients with type 2 diabetes in Greece: a cluster randomised trial

Thomas Karagiannis et al. BMJ Open. .

Abstract

Objective: To assess the efficacy of the Diabetes Medication Choice Decision Aid among patients with type 2 diabetes in Greece.

Design: Open-label cluster randomised controlled trial.

Setting: Primary and secondary care practices across Greece.

Participants: 5 sites allocated to the decision aid (n=101 patients) and 4 sites to control (n=103 patients).

Intervention: Clinicians and patients in the intervention arm used a decision aid, based on outcomes that both consider important when choosing among antihyperglycaemic medications. Patients in the control arm received usual care.

Outcome measures: The primary outcome was patient's level of decisional comfort after the initial clinical encounter. Secondary outcomes included patient's knowledge about type 2 diabetes and medications, and patient's and clinician's satisfaction. Adherence to prescribed antihyperglycaemic medication and change in glycated haemoglobin were assessed at 24 weeks.

Results: Patients in both arms had similar scores in overall decisional comfort (mean difference between the usual care and decision aid arms -6.9, 95% CI -21.5 to 7.7) and its subscales. Patients' knowledge was high in both arms (mean difference 2.3%, 95% CI -15.7% to 20.4%). Patients and clinicians in both groups were equally satisfied with the decision-making. No significant difference in medication adherence and glycaemic control was found across arms. Clinicians found the decision aid useful and reported that its integration in their daily routine was easy.

Conclusions: The decision aid was implemented and positively received in the clinical setting in Greece, in line with the patient-centred approach endorsed by current guidelines. However, this trial yielded imprecise results in terms of patient outcomes. Further research is needed to investigate the interaction between the patient and the clinician in order to clarify the association between the use of decision aids and implementation of shared decision-making.

Trial registration number: NCT01861756. Pre-results.

Keywords: Cluster randomised trial; Decision aid; Shared decision making; Type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Participant flow diagram. HbA1c, glycated haemoglobin.
See this image and copyright information in PMC

References

    1. Inzucchi SE, Bergenstal RM, Buse JB et al. . Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140–9. 10.2337/dc14-2441 - DOI - PubMed
    1. Saulsberry WJ, Coleman CI, Mearns ES et al. . Comparative efficacy and safety of antidiabetic drug regimens added to stable and inadequate metformin and thiazolidinedione therapy in type 2 diabetes. Int J Clin Pract 2015;69:1221–35. 10.1111/ijcp.12698 - DOI - PubMed
    1. Mearns ES, Saulsberry WJ, White CM et al. . Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in type 2 diabetes: a network meta-analysis. Diabet Med 2015;32:1530–40. 10.1111/dme.12837 - DOI - PubMed
    1. Griffin SJ, Borch-Johnsen K, Davies MJ et al. . Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 2011;378:156–67. 10.1016/S0140-6736(11)60698-3 - DOI - PMC - PubMed
    1. Sepucha KR, Fagerlin A, Couper MP et al. . How does feeling informed relate to being informed? The DECISIONS survey. Med Decis Making 2010;30(5 Suppl):77S–84S. 10.1177/0272989X10379647 - DOI - PubMed

Publication types

MeSH terms

Substances

Associated data